Form 4: Amedisys Director's Holdings Post-UnitedHealth Merger
Insider Transaction Report
Amedisys Director Paul B. K. Kusserow's equity and derivative holdings in Amedisys Inc. were converted or disposed of following the acquisition by UnitedHealth Group on August 14, 2025.
Summary
- Director Paul B. K. Kusserow's direct and indirect holdings in Amedisys Inc. were impacted by the acquisition by UnitedHealth Group.
- 439,124 shares of Common Stock and 621 shares held in a 401(k) plan were converted into the right to receive $101 per share in cash.
- 1,690 time-based Restricted Stock Units (RSUs) were cancelled and converted into the right to receive the $101 per share cash consideration.
- 80,602 fully vested stock options were converted into options to purchase UnitedHealth Group common stock, with adjusted exercise price and share count based on the Equity Award Exchange Ratio.
- Following these transactions, the reporting person holds 0 shares and 0 derivative securities of Amedisys Inc.
Sentiment
Score: 7
Explanation: The filing reports the expected outcome of a major corporate merger, which provided a fixed cash value for shares and converted options into the acquiring company's stock. This is a neutral to positive event for the reporting person as it represents the successful completion of a strategic transaction.
Positives
- The merger provided a cash consideration of $101 per share for common stock and RSUs, offering liquidity to shareholders.
- Existing stock options were converted into options for UnitedHealth Group stock, allowing continued participation in the acquiring company's equity.
Negatives
- The reporting person no longer holds direct equity in Amedisys Inc. as it became a wholly-owned subsidiary.
Future Outlook
The filing indicates that converted stock options will continue to be subject to the same terms and conditions as the original Amedisys options, but now for UnitedHealth Group common stock.
Industry Context
This Form 4 reflects the finalization of a significant merger in the healthcare sector, where UnitedHealth Group acquired Amedisys, a major home health and hospice provider. This consolidation aligns with broader trends of vertical integration and expansion within the healthcare industry, particularly in post-acute care services.
Stakeholder Impact
- Shareholders (Amedisys): Received $101 per share in cash, providing a clear exit value.
- Employees (Amedisys): RSUs and stock options were converted, indicating a transition of equity incentives to the acquiring company.
Next Steps
- The converted UnitedHealth Group options will continue to be subject to their original terms and conditions.
Key Dates
| Date | Description |
|---|---|
| 2023-06-26 | Date of the original Agreement and Plan of Merger between Amedisys, UnitedHealth Group, and Aurora Holdings Merger Sub Inc. |
| 2024-12-26 | Date of waiver modifying the Merger Agreement. |
| 2025-08-14 | Effective time of the Merger, when UnitedHealth Group acquired Amedisys, and the transaction date for the reported changes in beneficial ownership. |
| 2029-01-02 | Expiration date of the converted stock options. |
Keywords
Amedisys, UnitedHealth Group, Merger, Acquisition, Form 4, Insider Trading, Stock Options, RSUs, Common Stock, Paul B. K. Kusserow, Healthcare, Home Health
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.